Literature DB >> 22608128

A review of the chemistry of the genus Crataegus.

Jennifer E Edwards1, Paula N Brown, Nadia Talent, Timothy A Dickinson, Paul R Shipley.   

Abstract

Since the 1800s, natural health products that contain hawthorn (Crataegus spp.) have been used in North America for the treatment of heart problems such as hypertension, angina, arrhythmia, and congestive heart failure. Traditionally, Native American tribes used hawthorn (Crataegus spp.) to treat gastrointestinal ailments and heart problems, and consumed the fruit as food. Hawthorn also has a long history of use in Europe and China for food, and in traditional medicine. Investigations of Crataegus spp. typically focus on the identification and quantification of flavonoids and anthocyanins, which have been shown to have pharmacological activity. The main flavonoids found in Crataegus spp. are hyperoside, vitexin, and additional glycosylated derivatives of these compounds. Reviewed herein are the botany, ethnobotany, and traditional use of hawthorn while focusing on the phytochemicals that have been reported in Crataegus species, and the variation in the described chemistry between individual species.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22608128     DOI: 10.1016/j.phytochem.2012.04.006

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  26 in total

1.  Reticulate evolution in North American black-fruited hawthorns (Crataegus section Douglasia; Rosaceae): evidence from nuclear ITS2 and plastid sequences.

Authors:  M Zarrei; S Stefanović; T A Dickinson
Journal:  Ann Bot       Date:  2014-07-01       Impact factor: 4.357

2.  Ethanol extract of Zhongtian hawthorn lowers serum cholesterol in mice by inhibiting transcription of 3-hydroxy-3-methylglutaryl-CoA reductase via nuclear factor-kappa B signal pathway.

Authors:  Hai-Jie Hu; Xue-Gang Luo; Qing-Qing Dong; Ai Mu; Guo-Long Shi; Qiu-Tong Wang; Xiao-Ying Chen; Hao Zhou; Tong-Cun Zhang; Li-Wen Pan
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-28

3.  In Vitro Protection by Crataegus microphylla Extracts Against Oxidative Damage and Enzyme Inhibition Effects.

Authors:  Gülin Renda; Arzu Özel; Burak Barut; Büşra Korkmaz; Nurettin Yayli
Journal:  Turk J Pharm Sci       Date:  2018-04-02

Review 4.  Polyphenolic Composition of Crataegus monogyna Jacq.: From Chemistry to Medical Applications.

Authors:  Seyed Fazel Nabavi; Solomon Habtemariam; Touqeer Ahmed; Antoni Sureda; Maria Daglia; Eduardo Sobarzo-Sánchez; Seyed Mohammad Nabavi
Journal:  Nutrients       Date:  2015-09-11       Impact factor: 5.717

5.  DNA barcodes from four loci provide poor resolution of taxonomic groups in the genus Crataegus.

Authors:  Mehdi Zarrei; Nadia Talent; Maria Kuzmina; Jeanette Lee; Jensen Lund; Paul R Shipley; Saša Stefanović; Timothy A Dickinson
Journal:  AoB Plants       Date:  2015-04-28       Impact factor: 3.276

6.  Hydroxycinnamic Acid Derivatives Obtained from a Commercial Crataegus Extract and from Authentic Crataegus spp.

Authors:  Ulrich Kuczkowiak; Frank Petereit; Adolf Nahrstedt
Journal:  Sci Pharm       Date:  2014-08-21

Review 7.  Effect of crataegus usage in cardiovascular disease prevention: an evidence-based approach.

Authors:  Jie Wang; Xingjiang Xiong; Bo Feng
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-29       Impact factor: 2.629

8.  Heart ABCA1 and PPAR- α Genes Expression Responses in Male rats: Effects of High Intensity Treadmill Running Training and Aqueous Extraction of Black Crataegus-Pentaegyna.

Authors:  Abbass Ghanbari-Niaki; Safieyh Ghanbari-Abarghooi; Fatemeh Rahbarizadeh; Navabeh Zare-Kookandeh; Monireh Gholizadeh; Fatemeh Roudbari; Asghar Zare-Kookandeh
Journal:  Res Cardiovasc Med       Date:  2013-10-28

9.  Polyphenolic Compounds of Crataegus Berry, Leaf, and Flower Extracts Affect Viability and Invasive Potential of Human Glioblastoma Cells.

Authors:  Natalia Żurek; Olena Karatsai; Maria Jolanta Rędowicz; Ireneusz Tomasz Kapusta
Journal:  Molecules       Date:  2021-05-01       Impact factor: 4.411

10.  Evaluation of a crataegus-based multiherb formula for dyslipidemia: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Miao Hu; Weiwei Zeng; Brian Tomlinson
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.